Equity Overview
Price & Market Data
Price: $17.01
Daily Change: +$0.645 / 3.79%
Daily Range: $16.20 - $17.49
Market Cap: $830,979,456
Daily Volume: 122,493
Performance Metrics
1 Week: 18.47%
1 Month: 15.35%
3 Months: 26.39%
6 Months: 82.11%
1 Year: 81.35%
YTD: 7.87%
Company Details
Employees: 55
Sector: Health technology
Industry: Biotechnology
Country: United States
Details
Jade Biosciences, Inc. operates as a biotechnology company that develops therapies for inflammation and immunology indications in patients living with autoimmune diseases. It develops JADE101, a monoclonal antibody to block the A PRoliferation Inducing Ligand protein, which is in phase 1 clinical trial. The compnay also develops JADE201 and JADE-003, which are in preclinical development stage. Jade Biosciences, Inc. has a collaboration agreement with Paragon Therapeutics, Inc. Jade Biosciences, Inc. is based in Waltham, Massachusetts.